Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01993446Phase 2Completed
A Phase 2 trial of drm02 in rosacea, sponsored by Dermira, Inc.. Started Oct 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01993446.